Cancer is a general term for a large group of diseases, whose causes, characteristics, and occurrence can vary. All of them are characterized by the development of abnor mal cells that divide uncontrollably and infiltrate and disrupt normal body tissue. Cancer has a major impact on society across the world, and, in fact, there were 19.3 million new cases in 2020 worldwide (Fig. 1) (https://www.iarc.who.int/). Among these statistics, breast, lung, colorectal, prostate, and stomach highlight as the most common cancer types, with more than 1 million cases each. Moreover, according to the International Agency for Research on Cancer (IARC), the number of new cases per year is expected to rise to 29.5 million by 2040 (https://www.iarc.who.int/).

Clinical Trials Involving Chemotherapy- Based Nanocarriers in Cancer Therapy: State of the Art and Future Directions / Lopez-Mendez, Tania B.; Strippoli, Raffaele; Trionfetti, Flavia; Calvo, Pilar; Cordani, Marco; Juan Gonzalez-Valdivieso, And. - (2022).

Clinical Trials Involving Chemotherapy- Based Nanocarriers in Cancer Therapy: State of the Art and Future Directions

Raffaele Strippoli;Flavia Trionfetti;
2022

Abstract

Cancer is a general term for a large group of diseases, whose causes, characteristics, and occurrence can vary. All of them are characterized by the development of abnor mal cells that divide uncontrollably and infiltrate and disrupt normal body tissue. Cancer has a major impact on society across the world, and, in fact, there were 19.3 million new cases in 2020 worldwide (Fig. 1) (https://www.iarc.who.int/). Among these statistics, breast, lung, colorectal, prostate, and stomach highlight as the most common cancer types, with more than 1 million cases each. Moreover, according to the International Agency for Research on Cancer (IARC), the number of new cases per year is expected to rise to 29.5 million by 2040 (https://www.iarc.who.int/).
2022
Cancer Nanotechnology
nanotechnology; cancer
02 Pubblicazione su volume::02a Capitolo o Articolo
Clinical Trials Involving Chemotherapy- Based Nanocarriers in Cancer Therapy: State of the Art and Future Directions / Lopez-Mendez, Tania B.; Strippoli, Raffaele; Trionfetti, Flavia; Calvo, Pilar; Cordani, Marco; Juan Gonzalez-Valdivieso, And. - (2022).
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1663108
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 1
  • ???jsp.display-item.citation.isi??? ND
social impact